Literature DB >> 34314390

Natural killer cell immunosuppressive function requires CXCR3-dependent redistribution within lymphoid tissues.

Ayad Ali1,2,3, Laura M Canaday2,3, H Alex Feldman1,2,3, Hilal Cevik3,4, Michael T Moran2,3, Sanjeeth Rajaram3,5, Nora Lakes1,2, Jasmine A Tuazon3, Harsha Seelamneni3, Durga Krishnamurthy3, Eryn Blass6, Dan H Barouch6,7, Stephen N Waggoner1,2,3,4,8.   

Abstract

NK cell suppression of T cells is a key determinant of viral pathogenesis and vaccine efficacy. This process involves perforin-dependent elimination of activated CD4+ T cells during the first 3 days of infection. Although this mechanism requires cell-cell contact, NK cells and T cells typically reside in different compartments of lymphoid tissues at steady state. Here, we showed that NK cell suppression of T cells is associated with transient accumulation of NK cells within T cell-rich sites of the spleen during lymphocytic choriomeningitis virus infection. The chemokine receptor CXCR3 was required for this relocation and suppression of antiviral T cells. Accordingly, NK cell migration was mediated by type I IFN-dependent promotion of CXCR3 ligand expression. In contrast, adenoviral vectors that weakly induced type I IFN and did not stimulate NK cell inhibition of T cells also did not promote measurable redistribution of NK cells to T cell zones. Exogenous IFN rescued NK cell migration during adenoviral vector immunization. Thus, type I IFN and CXCR3 were critical for properly positioning NK cells to constrain antiviral T cell responses. Development of strategies to curtail migration of NK cells between lymphoid compartments may enhance vaccine-elicited immune responses.

Entities:  

Keywords:  Cellular immune response; Immunology; Innate immunity; NK cells; Vaccines

Mesh:

Substances:

Year:  2021        PMID: 34314390      PMCID: PMC8439606          DOI: 10.1172/JCI146686

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  31 in total

1.  Natural killer cell activation enhances immune pathology and promotes chronic infection by limiting CD8+ T-cell immunity.

Authors:  Philipp A Lang; Karl S Lang; Haifeng C Xu; Melanie Grusdat; Ian A Parish; Mike Recher; Alisha R Elford; Salim Dhanji; Namir Shaabani; Charles W Tran; Dilan Dissanayake; Ramtin Rahbar; Magar Ghazarian; Anne Brüstle; Jason Fine; Peter Chen; Casey T Weaver; Christoph Klose; Andreas Diefenbach; Dieter Häussinger; James R Carlyle; Susan M Kaech; Tak W Mak; Pamela S Ohashi
Journal:  Proc Natl Acad Sci U S A       Date:  2011-12-13       Impact factor: 11.205

2.  Intravascular staining for discrimination of vascular and tissue leukocytes.

Authors:  Kristin G Anderson; Katrin Mayer-Barber; Heungsup Sung; Lalit Beura; Britnie R James; Justin J Taylor; Lindor Qunaj; Thomas S Griffith; Vaiva Vezys; Daniel L Barber; David Masopust
Journal:  Nat Protoc       Date:  2014-01-02       Impact factor: 13.491

3.  Cutting edge: CD8+ T cell priming in the absence of NK cells leads to enhanced memory responses.

Authors:  Katrina Soderquest; Thierry Walzer; Biljana Zafirova; Linda S Klavinskis; Bojan Polić; Eric Vivier; Graham M Lord; Alfonso Martín-Fontecha
Journal:  J Immunol       Date:  2011-02-09       Impact factor: 5.422

Review 4.  Perforin and granzymes: function, dysfunction and human pathology.

Authors:  Ilia Voskoboinik; James C Whisstock; Joseph A Trapani
Journal:  Nat Rev Immunol       Date:  2015-06       Impact factor: 53.106

5.  Migratory Dendritic Cells, Group 1 Innate Lymphoid Cells, and Inflammatory Monocytes Collaborate to Recruit NK Cells to the Virus-Infected Lymph Node.

Authors:  Eric Wong; Ren-Huan Xu; Daniel Rubio; Avital Lev; Colby Stotesbury; Min Fang; Luis J Sigal
Journal:  Cell Rep       Date:  2018-07-03       Impact factor: 9.423

6.  Induced recruitment of NK cells to lymph nodes provides IFN-gamma for T(H)1 priming.

Authors:  Alfonso Martín-Fontecha; Lindy L Thomsen; Sara Brett; Craig Gerard; Martin Lipp; Antonio Lanzavecchia; Federica Sallusto
Journal:  Nat Immunol       Date:  2004-11-07       Impact factor: 25.606

7.  Interferon-γ mediates chemokine-dependent recruitment of natural killer cells during viral infection.

Authors:  Melissa A Pak-Wittel; Liping Yang; Dorothy K Sojka; Joshua G Rivenbark; Wayne M Yokoyama
Journal:  Proc Natl Acad Sci U S A       Date:  2012-12-17       Impact factor: 11.205

8.  The abundant NK cells in human secondary lymphoid tissues require activation to express killer cell Ig-like receptors and become cytolytic.

Authors:  Guido Ferlazzo; Dolca Thomas; Shao-Lee Lin; Kiera Goodman; Barbara Morandi; William A Muller; Alessandro Moretta; Christian Münz
Journal:  J Immunol       Date:  2004-02-01       Impact factor: 5.422

Review 9.  The interferon system and vaccinia virus evasion mechanisms.

Authors:  Beatriz Perdiguero; Mariano Esteban
Journal:  J Interferon Cytokine Res       Date:  2009-09       Impact factor: 2.607

10.  Adenovirus Vector Vaccination Impacts NK Cell Rheostat Function following Lymphocytic Choriomeningitis Virus Infection.

Authors:  Eryn Blass; Malika Aid; Amanda J Martinot; Rafael A Larocca; Zi Han Kang; Alexander Badamchi-Zadeh; Pablo Penaloza-MacMaster; R Keith Reeves; Dan H Barouch
Journal:  J Virol       Date:  2018-05-14       Impact factor: 5.103

View more
  5 in total

1.  Inclusion criteria: how NK cells gain access to T cells.

Authors:  Tonya J Webb
Journal:  J Clin Invest       Date:  2021-09-15       Impact factor: 19.456

Review 2.  Targeting natural killer cells to enhance vaccine responses.

Authors:  Andrew Cox; Hilal Cevik; H Alex Feldman; Laura M Canaday; Nora Lakes; Stephen N Waggoner
Journal:  Trends Pharmacol Sci       Date:  2021-07-23       Impact factor: 17.638

Review 3.  Immune Checkpoints and Innate Lymphoid Cells-New Avenues for Cancer Immunotherapy.

Authors:  Nicolas Jacquelot; Maryam Ghaedi; Kathrin Warner; Douglas C Chung; Sarah Q Crome; Pamela S Ohashi
Journal:  Cancers (Basel)       Date:  2021-11-27       Impact factor: 6.639

4.  Targeting integrin αvβ3 with indomethacin inhibits patient-derived xenograft tumour growth and recurrence in oesophageal squamous cell carcinoma.

Authors:  Fangfang Liu; Qiong Wu; Wei Han; Kyle Laster; Yamei Hu; Fayang Ma; Hanyong Chen; Xueli Tian; Yan Qiao; Hui Liu; Dong Joon Kim; Zigang Dong; Kangdong Liu
Journal:  Clin Transl Med       Date:  2021-10

5.  CXCL11 expressing C57BL/6 mice have intact adaptive immune responses to viral infection.

Authors:  Lennard Dalit; Carolina Alvarado; Lisan Küijper; Andrew J Kueh; Ashley Weir; Angela D'Amico; Marco J Herold; James E Vince; Stephen L Nutt; Joanna R Groom
Journal:  Immunol Cell Biol       Date:  2022-03-20       Impact factor: 5.853

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.